1. Home
  2. CRBU vs AISP Comparison

CRBU vs AISP Comparison

Compare CRBU & AISP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • AISP
  • Stock Information
  • Founded
  • CRBU 2011
  • AISP 2006
  • Country
  • CRBU United States
  • AISP United States
  • Employees
  • CRBU N/A
  • AISP N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • AISP Blank Checks
  • Sector
  • CRBU Health Care
  • AISP Finance
  • Exchange
  • CRBU Nasdaq
  • AISP Nasdaq
  • Market Cap
  • CRBU 93.0M
  • AISP 107.6M
  • IPO Year
  • CRBU 2021
  • AISP N/A
  • Fundamental
  • Price
  • CRBU $1.07
  • AISP $4.99
  • Analyst Decision
  • CRBU Strong Buy
  • AISP Strong Buy
  • Analyst Count
  • CRBU 4
  • AISP 1
  • Target Price
  • CRBU $8.50
  • AISP $6.00
  • AVG Volume (30 Days)
  • CRBU 943.1K
  • AISP 1.2M
  • Earning Date
  • CRBU 05-08-2025
  • AISP 05-15-2025
  • Dividend Yield
  • CRBU N/A
  • AISP N/A
  • EPS Growth
  • CRBU N/A
  • AISP N/A
  • EPS
  • CRBU N/A
  • AISP N/A
  • Revenue
  • CRBU $9,918,000.00
  • AISP $17,978,226.00
  • Revenue This Year
  • CRBU N/A
  • AISP $34.30
  • Revenue Next Year
  • CRBU $161.81
  • AISP $59.47
  • P/E Ratio
  • CRBU N/A
  • AISP N/A
  • Revenue Growth
  • CRBU N/A
  • AISP N/A
  • 52 Week Low
  • CRBU $0.66
  • AISP $1.90
  • 52 Week High
  • CRBU $3.00
  • AISP $7.66
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 57.50
  • AISP 56.73
  • Support Level
  • CRBU $0.98
  • AISP $5.05
  • Resistance Level
  • CRBU $1.21
  • AISP $5.60
  • Average True Range (ATR)
  • CRBU 0.10
  • AISP 0.45
  • MACD
  • CRBU 0.02
  • AISP 0.03
  • Stochastic Oscillator
  • CRBU 68.23
  • AISP 57.53

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permission-based architecture.

Share on Social Networks: